Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Apr 1;95(5):937-938.
doi: 10.1002/ccd.28877.

Not to worry (most of the time)

Donald J Hagler  1
Affiliations
Editorial

Not to worry (most of the time)

Donald J Hagler. Catheter Cardiovasc Interv. .

Abstract

Most (87.6%) of residual atrial L-R shunts after Gore Cardioform septal occluder implant disappear by 12 months. Residual leaks at implantation were more common in larger defects with smaller retro-aortic rims, and multiple fenestrations. While most residual defects close in 12 months, we unfortunately do not yet have a clear idea why or which of the 13% do not close.

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Gordon BM, Abudayyeh I, Goble J, Collado NA, Paolillo J. Here today, gone tomorrow: outcomes of residual leak following secundum atrial septal defect closure with the gore CARDIOFORM septal occluder. Catheter Cardiovasc Interv. 2020;95:932-936.
    1. Prieto LR. Outcomes after device closure of atrial septal defect in children (editorial comment). JACC Cardiovasc Interv. 2018;11(8):805-807.
    1. Jalal Z, Hascoet S, Gronier C, et al. Long-term outcomes after percutnaeous closrue of ostium secundum atrial septal defect in the young: a nationwide cohort study. JACC Cardiovasc Interv. 2018;11:795-804.
    1. Grohmann J, Wildberg C, Zartner P, et al. Multicenter midterm follow-up results using the Gore septal occluder for atrila septal defect closure in pediatric patients. Catheter Cardiovasc Interv. 2017;89:E226-E232.
    1. de Hemptinne Q, Horlick EM, Osten MD, et al. Initial clinical experience with the Gore (R) CARDIOFORM ASD occluder for transcatheter atrial septal defect closure. Catheter Cardiovasc Interv. 2017;90:495-503.

LinkOut - more resources